Laurolactam-Based Transparent PA Resin Pellets from Canada
Primary pellets of laurolactam-isophthalic acid-bis(4-amino-3-methylcyclohexyl)methane copolymer for medical device molding. HTS 3908.90.2000 due to specific naming in polyamide subheadings with predominant monomer compliance. Biocompatible and sterilizable for healthcare uses.
Duty Rate — Canada → United States
10%
Rate breakdown
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Comply with FDA import requirements alongside CBP; provide biocompatibility test data; declare as primary form only - not compounded